Bessemer Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $219K | Sell |
7,949
-3,655
| -31% | -$101K | ﹤0.01% | 1072 |
|
2025
Q1 | $329K | Buy |
11,604
+6,642
| +134% | +$188K | ﹤0.01% | 970 |
|
2024
Q4 | $206K | Sell |
4,962
-658
| -12% | -$27.3K | ﹤0.01% | 1065 |
|
2024
Q3 | $376K | Sell |
5,620
-2,324
| -29% | -$155K | ﹤0.01% | 967 |
|
2024
Q2 | $943K | Buy |
7,944
+686
| +9% | +$81.4K | ﹤0.01% | 669 |
|
2024
Q1 | $774K | Buy |
7,258
+276
| +4% | +$29.4K | ﹤0.01% | 713 |
|
2023
Q4 | $694K | Buy |
6,982
+1,065
| +18% | +$106K | ﹤0.01% | 735 |
|
2023
Q3 | $611K | Sell |
5,917
-5,553
| -48% | -$573K | ﹤0.01% | 745 |
|
2023
Q2 | $1.39M | Buy |
11,470
+4,202
| +58% | +$511K | ﹤0.01% | 564 |
|
2023
Q1 | $1.12M | Sell |
7,268
-323
| -4% | -$49.6K | ﹤0.01% | 563 |
|
2022
Q4 | $1.36M | Buy |
7,591
+1,210
| +19% | +$217K | ﹤0.01% | 524 |
|
2022
Q3 | $755K | Sell |
6,381
-1,081
| -14% | -$128K | ﹤0.01% | 639 |
|
2022
Q2 | $1.07M | Buy |
7,462
+4,276
| +134% | +$611K | ﹤0.01% | 562 |
|
2022
Q1 | $548K | Buy |
3,186
+932
| +41% | +$160K | ﹤0.01% | 618 |
|
2021
Q4 | $573K | Sell |
2,254
-97
| -4% | -$24.7K | ﹤0.01% | 603 |
|
2021
Q3 | $905K | Buy |
2,351
+2,251
| +2,251% | +$867K | ﹤0.01% | 435 |
|
2021
Q2 | $24K | Buy |
+100
| New | +$24K | ﹤0.01% | 1203 |
|
2020
Q4 | – | Sell |
-60
| Closed | -$4K | – | 1535 |
|
2020
Q3 | $4K | Sell |
60
-360
| -86% | -$24K | ﹤0.01% | 1215 |
|
2020
Q2 | $27K | Buy |
+420
| New | +$27K | ﹤0.01% | 1421 |
|